Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

April 26, 2015 10:21 PM ET


Company Overview of Intra-Cellular Therapies, Inc.

Key Executives for Intra-Cellular Therapies, Inc.

NameBoard RelationshipsTitleAge
Sharon Mates Ph.D.19 RelationshipsCo-Founder, Chairman, Chief Executive Officer and President61
Allen A. Fienberg Ph.D.No RelationshipsCo-Founder and Vice President of Business Development54
Paul Greengard Ph.D.83 RelationshipsCo-Founder and Chairman of Scientific Advisory Board--
Lawrence J. Hineline CPANo RelationshipsChief Financial Officer, Principal Accounting Officer, Vice President of Finance and Secretary58
Michael Halstead No RelationshipsSenior Vice President and General Counsel40

Intra-Cellular Therapies, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sharon Mates Ph.D. 19 RelationshipsIntra-Cellular Therapies, Inc.61
Paul Greengard Ph.D. 83 RelationshipsIntra-Cellular Therapies, Inc.--
Joel S. Marcus J.D., CPA 258 RelationshipsAlexandria Real Estate Equities, Inc.67
Christopher D. Alafi Ph.D. 20 RelationshipsAlafi Capital Company LLC51
Carol A. Tamminga M.D. 44 RelationshipsACADIA Pharmaceuticals Inc.--
View All Board Members

Intra-Cellular Therapies, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee BSRobert L. Van Nostrand40 Relationships2 Executives
Compensation Committee J.D., CPAJoel S. Marcus258 Relationships3 Executives
Nominating Committee Ph.D.Christopher D. Alafi20 Relationships3 Executives
Corporate Governance Committee Ph.D.Christopher D. Alafi20 Relationships3 Executives
Advisory Board M.D.Carol A. Tamminga44 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation$302.6K
Total Value of Options$1.1M
Compensation as of Fiscal Year 2013
Intra-Cellular Therapies, Inc. CEO Compensation
Industry Average


The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET
David Charne Joins Aunt Fannie's Board of Directors
April 14, 2015 1:38 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intra-Cellular Therapies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at